Tag Archives: AstraZeneca

AstraZeneca Issues New Data After Rebuke By Feds

The New York Times reports: AstraZeneca reiterated on Wednesday that its Covid-19 vaccine was very effective at preventing the disease, based on more recent data than was included when the company announced the interim results of its U.S. clinical trial on Monday. The company said in a news release that its vaccine was 76 percent effective at preventing Covid-19. That …

Read More »

Feds Question Data In AstraZeneca Vaccine Trial

Reuters reports: The Data Safety Monitoring Board (DSMB), an independent committee overseeing the trial, has “expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data,” the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released after midnight in the United States. The …

Read More »

US Study: AstraZenaca Vax Found To Be 79% Effective

The New York Times reports: The coronavirus vaccine developed by AstraZeneca and the University of Oxford provided strong protection against Covid-19 in a large clinical trial in the United States, completely preventing the worst outcomes from the disease while causing no serious side effects, according to results announced on Monday. The findings, announced in a news release from AstraZeneca, may …

Read More »

AstraZeneca Vax Shows “Strong Effect” With One Dose

The Washington Post reports: Researchers at Oxford University released new results from their vaccine, which is being manufactured by British-Swedish firm AstraZeneca, showing it gives 76 percent protection for three months after just one dose. Testing also reveals that those vaccinated are much less likely to transmit the disease, which will help stem the continuing spread of the virus. The …

Read More »

New Trial For Oxford Vax As UK Considers Approval

The Associated Press reports: The British government said Friday it has formally asked the country’s medicines regulator to assess whether a coronavirus vaccine developed by AstraZeneca and Oxford University should be authorized for use. The step comes amid questions about preliminary results from trials of the jab, after the company and the university acknowledged that the most encouraging part of …

Read More »

AstraZeneca Resumes COVID Vaccine Trials In UK

CNBC reports: Phase three trials for AstraZeneca’s coronavirus vaccine have resumed in the U.K. after they were halted earlier this week over safety concerns, the company announced Saturday. AstraZeneca said it received confirmation from the United Kingdom’s Medicines Health Regulatory Authority that it was safe to resume clinical trials. The company declined to disclose medical information about the pause of …

Read More »

Vax Trial Paused After Adverse Reaction In Volunteer

STAT News reports: A large, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca and the University of Oxford at dozens of sites across the U.S. has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom. A spokesperson for AstraZeneca, a frontrunner in the race for a Covid-19 vaccine, …

Read More »